VAERS Explorer
Back to explore

Report #2865184

Received Oct 12, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
79 yrs
State
PA
Recovered
Not recovered
Vaccinated
Oct 9, 2025
Onset
Oct 12, 2025
Days to onset
3
Hospital days
—

Vaccines (2)

TypeNameManufacturerDoseLotRoute / Site
COVID19COVID19 (COVID19 (PFIZER-BIONTECH))PFIZER\BIONTECH1NA0587IM / LA
PNC21PNEUMO (CAPVAXIVE)MERCK & CO. INC.1Z009681IM / LA

Symptoms (4)

Injection site erythemaInjection site inflammationInjection site painInjection site reaction

Symptom narrative

Manifestation of local, injection site reaction after administration of both Capvaxive 21 and Comirnaty on anatomical site. Marked erythema, inflammation and pain for a period of 3 or more days since administration

Lab data

N/A